Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,209,492 papers from all fields of science
Search
Sign In
Create Free Account
ASP2151
Known as:
ASP 2151
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Oxadiazoles
amenamevir
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Pharmacokinetics and Dialyzability of a Single Oral Dose of Amenamevir, an Anti-Herpes Drug, in Hemodialysis Patients
S. Tsuruoka
,
T. Endo
,
Mizuna Seo
,
Naoto Hashimoto
Advances in Therapy
2020
Corpus ID: 218762246
Introduction Amenamevir (ASP2151), a herpesvirus helicase-primase inhibitor, is currently used for the treatment of herpes zoster…
Expand
2016
2016
Integrative pharmacokinetic-pharmacodynamic modeling and simulation of amenamevir (ASP2151) for treatment of recurrent genital herpes.
A. Takada
,
M. Katashima
,
+5 authors
Y. Yano
Drug Metabolism and Pharmacokinetics
2016
Corpus ID: 36728076
2015
2015
IMS-P 22 Discovery of Amenamevir ( ASP 2151 ) , a Helicase-Primase Inhibitor as an Antiviral Drug against Varicella-Zoster Virus and Herpes Simplex Virus Types 1 and 2 ○
W. Hamaguchi
,
T. Kontani
,
J. Miyata
,
Shugo Honda
,
Hiroshi Suzuki
,
M. Takeuchi
2015
Corpus ID: 52211383
2015
2015
Regulated bioanalysis of conformers - A case study with ASP2151 in dog plasma and urine.
Yoshiaki Ohtsu
,
Shohei Otsuka
,
Takeshi Nakamura
,
K. Noguchi
Journal of chromatography. B, Analytical…
2015
Corpus ID: 23686775
2014
2014
Statistical analysis of Amenamevir (ASP2151) between pharmacokinetics and clinical efficacies with non‐linear effect model for the treatment of genital herpes
A. Takada
,
M. Katashima
,
A. Kaibara
,
T. Sawamoto
,
Wenhui Zhang
,
J. Keirns
Clinical pharmacology in drug development
2014
Corpus ID: 22595598
Amenamevir is the international non‐proprietary name for ASP2151 synthesized by Astellas Pharma, Inc. It is a structurally novel…
Expand
2013
2013
Phramacological study of ASP2151 (amenamevir),helicase-primase inhibitor possessing antiviral activity against varicella-zoster virus and herpes simplex virus type 1 and 2
長野 浩治
2013
Corpus ID: 86196531
2013
2013
新規抗ヘルペスウイルス剤 amenamevir (ASP2151) の臨床効果予測に関する研究
勝俣 清光
2013
Corpus ID: 87393371
2012
2012
Pharmacokinetics and Pharmacodynamics of ASP2151, a Helicase-Primase Inhibitor, in a Murine Model of Herpes Simplex Virus Infection
Kiyomitsu Katsumata
,
Koji Chono
,
+4 authors
Hiroshi Suzuki
Antimicrobial Agents and Chemotherapy
2012
Corpus ID: 44553081
ABSTRACT ASP2151 (amenamevir) is a helicase-primase inhibitor against herpes simplex virus 1 (HSV-1), HSV-2, and varicella zoster…
Expand
2012
2012
Efficacy of ASP2151, a helicase-primase inhibitor, against thymidine kinase-deficient herpes simplex virus type 2 infection in vitro and in vivo.
T. Himaki
,
Y. Masui
,
+6 authors
K. Shiraki
Antiviral Research
2012
Corpus ID: 24085548
2010
2010
ASP 2151 , a novel helicase – primase inhibitor , possesses antiviral activity against varicella – zoster virus and herpes simplex virus types 1 and 2
Koji Chono
,
Kiyomitsu Katsumata
,
+6 authors
Hiroshi Suzuki
2010
Corpus ID: 41957935
Methods: The inhibitory effect of ASP2151 on enzymatic activities associated with a recombinant HSV-1 helicase–primase complex…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE